A Phase 1 clinical trial has investigated the effect of umbilical cord-derived MSCs on the immune systems of Lupus patients. Although the study was small, positive results were observed 24 weeks post-treatment.
A new study suggests that umbilical cord tissue could one day be used to treat chronic, non-healing diabetic foot ulcers. EpiCord, a thick membrane product produced from umbilical cords, has been studied and tested as a form of wound dressing and healing for the ulcers.
A joint US and Chinese clinical trial has successfully demonstrated dental tissue regrowth using stem cells from baby teeth. The Phase 1 trial suggests a promising solution to injury-caused tooth damage in children with young adult teeth.
Researchers at the Stowers Institute of Medical Research have found another way to expand/multiply blood-forming, adult stem cells from umbilical cord blood. The discovery increases the potential of a single stem cell sample in treating more conditions.
Pioneering research by University of Adelaide could offer a huge step forward to treating patients with cystic fibrosis (CF). The research shows that the cells causing the genetic disorder could be replaced with healthy cells.